Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ATG NYSEARCA:FBT NASDAQ:SAAS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATGAtlanta GoldC$0.03+∞C$0.03C$0.03▼C$0.06C$2.28MN/A55,868 shs3,200 shsFBTFirst Trust NYSE Arca Biotechnology Index Fund$164.36+0.1%$163.26$141.38▼$183.60$1.02B0.7922,843 shs10,981 shsSAAS(SAAS)$0.01$0.00$7.15▼$13.99N/AN/A1.05 million shs200,000 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATGAtlanta Gold0.00%0.00%0.00%0.00%0.00%FBTFirst Trust NYSE Arca Biotechnology Index Fund+0.06%-1.06%+0.37%+0.27%-1.85%SAAS(SAAS)0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATGAtlanta GoldN/AN/AN/AN/AN/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATGAtlanta Gold 0.00N/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index Fund 2.64Moderate Buy$164.36N/ASAAS(SAAS) 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATGAtlanta GoldN/AN/AN/AN/AC$0.39 per shareN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATGAtlanta GoldN/A-C$0.02N/A∞N/AN/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/A21.72∞N/AN/AN/AN/AN/ASAAS(SAAS)N/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATGAtlanta GoldN/AN/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index Fund$1.170.71%N/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATGAtlanta Gold31.940.00N/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/ASAAS(SAAS)N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATGAtlanta GoldN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/ASAAS(SAAS)93.53%Insider OwnershipCompanyInsider OwnershipATGAtlanta GoldN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/ASAAS(SAAS)6.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATGAtlanta GoldN/A76.15 millionN/ANot OptionableFBTFirst Trust NYSE Arca Biotechnology Index FundN/A6.20 millionN/ANot OptionableSAAS(SAAS)N/AN/AN/ANot OptionableSAAS, FBT, ATG, and GBG HeadlinesRecent News About These CompaniesHow AI Is Rewriting The Rules Of SaaS PricingAugust 1 at 12:51 PM | forbes.comFrom Risk to Resilience: A SaaS Provider's Blueprint for Financial Services SecurityAugust 1 at 7:50 AM | techradar.comTWill AI agents eat the SaaS market? Experts are splitAugust 1 at 2:49 AM | cio.comCHow Colombo-born SaaS firm WSO2 is building world-class software outside the Silicon ValleyAugust 1 at 2:49 AM | yourstory.comYIndia can replicate SaaS success in cybersecurity: Acccel partnerJuly 30 at 9:40 PM | financialexpress.comFHow Using AI Simplifies SaaS Security: Smarter Investigations Start with AskOmniJuly 30 at 9:40 PM | securityboulevard.comSKnock ’em On Their SaaS; Spotify Misses The SpotJuly 30 at 4:39 PM | adexchanger.comACommvault raises FY26 revenue and ARR growth targets as SaaS momentum acceleratesJuly 29, 2025 | msn.comBuild an AI SaaS App in Minutes Writing a Single Line of CodeJuly 28, 2025 | geeky-gadgets.comGJeffry Jared Davies Pioneers Cross-Platform SAAS Security with xShield for the Privacy-Conscious ConsumerJuly 25, 2025 | msn.comWhy Every SaaS Startup Needs a Solid Financial ModelJuly 25, 2025 | msn.comStormrock founders announce Nemesis: A Swiss Incubator and AI SaaS for E-Commerce BrandsJuly 24, 2025 | manilatimes.netMComviva advances AI and SaaS transformation through AWS partnershipJuly 24, 2025 | voicendata.comVQ2 2025 Saw Resurgence of SaaS, Tech IPO Momentum, with Debuts from eToro, Circle, Chime : AnalysisJuly 23, 2025 | crowdfundinsider.comCWhy IPG is shifting to outcome-based models and selling AI tools as SaaSJuly 23, 2025 | thedrum.comTZoho will go big on vertical SaaS… market is ripe for disruption, says CEO Mani VembuJuly 21, 2025 | moneycontrol.comKyunki Saas Bhi Kabhi... BTS video hints at original cast's return with Smriti IraniJuly 21, 2025 | msn.comKyunki Saas Bhi Kabhi Bahu Thi Star Hiten Tejwani Wins Hearts At ‘Sanghavi And Sons’ Special ScreeningsJuly 21, 2025 | filmibeat.comFKyunki Saas Bhi Kabhi Bahu Thi 2: Smriti Irani’s Tulsi Promises ‘New Zamana With Old Sanskaar’ But I Know Who Might Be Having Trust Issues!July 21, 2025 | koimoi.comKKyunki Saas Bhi Kabhi Bahu Thi 2: From Smriti Irani to Amar Upadhyay; Here’s how much the star cast is charging per episodeJuly 21, 2025 | msn.comMedia Sentiment Over TimeSAAS, FBT, ATG, and GBG Company DescriptionsAtlanta Gold CVE:ATGC$0.03 +0.03 (+∞) As of 05/1/2019Atlanta Gold Inc. operates as a junior gold exploration and development company in the United States. Its principal property is the Atlanta gold property that covers an area of 2,159 acres located in Idaho. The company was formerly known as Twin Mining Corporation and changed its name to Atlanta Gold Inc. in March 2007. Atlanta Gold Inc. was founded in 1985 and is headquartered in Toronto, Canada.First Trust NYSE Arca Biotechnology Index Fund NYSEARCA:FBT$164.36 +0.10 (+0.06%) As of 08/1/2025 04:10 PM EasternThe First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.(SAAS) NASDAQ:SAASinContact, Inc. (inContact) is a provider of cloud contact center software solutions. The Company provides a range of cloud contact center call routing, self-service and agent optimization solutions. The Company operates through two business segments: Software and Network connectivity. inContact's Software segment includes the services related to the delivery of its cloud contact center software solutions. Its Network connectivity segment includes the voice and data long distance services provided to customers. It offers its products and services to its customers in approximately five vertical markets, such as customer services and sales business process outsourcers (BPOs), retail and direct response, healthcare providers, utilities, and state and local Government. It provides software, which includes Automatic call distributing, Computer telephony integration, Interactive voice response with speech recognition, Outbound dialer, Screen recording and Interactive reporting tool. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.